clioquinol has been researched along with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SH; Chen, SY; Chen, Y; Gu, LQ; Huang, ZS; Li, YP; Ou, TM; Tan, JH | 1 |
| Guo, Y; Huang, L; Li, X; Lu, C; Luo, HB; Luo, Z; Yan, J; Yan, M | 1 |
| Kador, PF; Kawada, H | 1 |
| Cai, P; Kong, LY; Li, F; Liu, QH; Wang, J; Wang, XB; Wu, JJ; Yang, XL | 1 |
| Liu, P; Liu, ZP; Shi, XL; Wu, JD | 1 |
5 other study(ies) available for clioquinol and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Cell Line, Tumor; Chelating Agents; Curcumin; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Structure; Peptide Fragments; Reactive Oxygen Species; Stereoisomerism; Structure-Activity Relationship | 2011 |
Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blood-Brain Barrier; Cholinesterase Inhibitors; Clioquinol; Drug Design; Humans; Mice; Monoamine Oxidase Inhibitors; Peptide Fragments; Resveratrol; Stilbenes | 2013 |
Orally Bioavailable Metal Chelators and Radical Scavengers: Multifunctional Antioxidants for the Coadjutant Treatment of Neurodegenerative Diseases.
Topics: Alzheimer Disease; Animals; Antioxidants; Biological Availability; Brain; Cell Line, Tumor; Cell Survival; Chelating Agents; Clioquinol; Dose-Response Relationship, Drug; Epithelial Cells; Female; Free Radical Scavengers; Glutathione; Humans; Male; Metals; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases; Pyrimidines; Retina | 2015 |
Synthesis and pharmacological evaluation of novel chromone derivatives as balanced multifunctional agents against Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Apoptosis; Binding Sites; Blood-Brain Barrier; Chromones; Copper; Humans; Hydrogen Peroxide; Inhibitory Concentration 50; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Protein Structure, Tertiary; Rats; Reactive Oxygen Species; Structure-Activity Relationship | 2017 |
Synthesis and evaluation of novel GSK-3β inhibitors as multifunctional agents against Alzheimer's disease.
Topics: Alzheimer Disease; Amides; Amines; Animals; Antioxidants; Blood-Brain Barrier; Cell Line; Chelating Agents; Drug Design; Glycogen Synthase Kinase 3 beta; Humans; PC12 Cells; Protein Aggregation, Pathological; Protein Kinase Inhibitors; Rats; Structure-Activity Relationship; tau Proteins | 2019 |